Economic and clinical burden of comorbidities among patients with acromegaly
Open Access
- 1 August 2021
- journal article
- research article
- Published by Elsevier in Growth Hormone & IGF Research
- Vol. 59, 101389
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Treatments, complications, and healthcare utilization associated with acromegaly: a study in two large United States databasesPituitary, 2013
- Deaths Among Adult Patients With Hypopituitarism: Hypocortisolism During Acute Stress, and De Novo Malignant Brain Tumors Contribute to an Increased MortalityThe Journal of Clinical Endocrinology & Metabolism, 2013
- Clinical, quality of life, and economic value of acromegaly disease controlPituitary, 2011
- Preference values associated with stage III colon cancer and adjuvant chemotherapyQuality of Life Research, 2010
- UTILITY INDICES IN OBSTRUCTIVE SLEEP APNEA PATIENTSChest, 2008
- AcromegalyNew England Journal of Medicine, 2006
- Preference-Based EQ-5D Index Scores for Chronic Conditions in the United StatesMedical Decision Making, 2006
- Cost-of-illness study in acromegalic patients in ItalyJournal of Endocrinological Investigation, 2004
- Prevalence of Sleep-disordered Breathing in WomenAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Effects of Age on Sleep Apnea in Men: I. Prevalence and SeverityAmerican Journal of Respiratory and Critical Care Medicine, 1998